Gland Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE068V01023
  • NSEID: GLAND
  • BSEID: 543245
INR
2,198.35
1.2 (0.05%)
BSENSE

Jun 18

BSE+NSE Vol: 11.09 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
6,430.65
5,616.50
5,664.72
3,624.60
4,400.71
3,462.88
2,633.24
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,430.65
5,616.50
5,664.72
3,624.60
4,400.71
3,462.88
2,633.24
Raw Material Cost
2,239.75
1,972.48
2,022.14
1,716.75
2,046.86
1,749.16
1,090.25
Purchase of Finished goods
6.60
14.49
23.07
15.59
25.67
16.20
18.67
(Increase) / Decrease In Stocks
-3.42
103.41
127.89
-46.92
36.69
-273.49
-6.90
Employee Cost
1,628.84
1,401.56
1,256.89
403.26
338.57
311.36
277.66
Power Cost
202.85
199.15
229.99
124.84
95.05
74.59
78.50
Manufacturing Expenses
0.00
0.01
-0.01
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
726.48
656.48
671.68
386.31
347.71
282.83
219.59
Total Expenditure (Excl Depreciation)
4,801.10
4,347.58
4,331.65
2,599.83
2,890.55
2,160.65
1,677.77
Operating Profit (PBDIT) excl Other Income
1,629.55
1,268.92
1,333.07
1,024.77
1,510.16
1,302.23
955.47
Other Income
316.33
213.61
170.24
240.46
223.94
134.78
139.17
Operating Profit (PBDIT)
1,945.88
1,482.53
1,503.31
1,265.23
1,734.10
1,437.01
1,094.64
Interest
33.28
42.00
26.20
7.45
5.24
3.41
7.18
Exceptional Items
-24.35
0.00
0.00
-56.46
0.00
0.00
0.00
Gross Profit (PBDT)
1,888.25
1,440.53
1,477.11
1,201.32
1,728.86
1,433.60
1,087.46
Depreciation
423.67
377.87
344.57
146.74
110.30
98.78
94.59
Profit Before Tax
1,464.58
1,062.66
1,132.54
1,054.58
1,618.55
1,334.81
992.87
Tax
437.26
364.13
360.08
273.54
406.89
337.85
220.01
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,027.32
698.53
772.46
781.04
1,211.66
996.96
772.86
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,027.32
698.53
772.46
781.04
1,211.66
996.96
772.86
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,027.32
698.53
772.46
781.04
1,211.66
996.96
772.86
Equity Capital
16.48
16.48
16.47
16.47
16.43
16.36
15.50
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
10,341.47
9,134.27
8,707.37
7,942.25
7,141.19
5,886.88
3,630.74
Earnings per share (EPS)
62.34
42.39
46.9
47.42
73.75
60.94
49.86
Diluted Earnings per share
62.28
42.4
46.89
47.43
73.64
62.99
49.88
Operating Profit Margin (Excl OI)
25.34%
22.59%
23.53%
28.27%
34.32%
37.61%
36.28%
Gross Profit Margin
29.36%
25.65%
26.08%
33.14%
39.29%
41.4%
41.3%
PAT Margin
15.98%
12.44%
13.64%
21.55%
27.53%
28.79%
29.35%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 14.50% vs -0.85% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is 47.07% vs -9.57% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 28.42% vs -4.81% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -20.76% vs 60.31% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Gland Pharma With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
6,430.65
3,821.67
2,608.98
68.27%
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,430.65
3,821.67
2,608.98
68.27%
Raw Material Cost
2,239.75
436.15
1,803.60
413.53%
Purchase of Finished goods
6.60
910.45
-903.85
-99.28%
(Increase) / Decrease In Stocks
-3.42
4.46
-7.88
-176.68%
Employee Cost
1,628.84
607.25
1,021.59
168.23%
Power Cost
202.85
0.00
202.85
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
726.48
554.16
172.32
31.10%
Total Expenditure (Excl Depreciation)
4,801.10
2,512.47
2,288.63
91.09%
Operating Profit (PBDIT) excl Other Income
1,629.55
1,309.20
320.35
24.47%
Other Income
316.33
145.36
170.97
117.62%
Operating Profit (PBDIT)
1,945.88
1,454.56
491.32
33.78%
Interest
33.28
2.73
30.55
1,119.05%
Exceptional Items
-24.35
20.62
-44.97
-218.09%
Gross Profit (PBDT)
1,888.25
1,472.45
415.80
28.24%
Depreciation
423.67
66.44
357.23
537.67%
Profit Before Tax
1,464.58
1,406.01
58.57
4.17%
Tax
437.26
370.03
67.23
18.17%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
1,027.32
1,035.98
-8.66
-0.84%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
1,027.32
1,035.98
-8.66
-0.84%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,027.32
1,035.98
-8.66
-0.84%
Equity Capital
16.48
169.41
-152.93
-90.27%
Face Value
1.00
10.00
0.00
Reserves
10,341.47
2,098.01
8,243.46
392.92%
Earnings per share (EPS)
62.34
61.15
1.19
1.95%
Diluted Earnings per share
62.28
61.15
1.13
1.85%
Operating Profit Margin (Excl OI)
25.34%
34.26%
0.00
-8.92%
Gross Profit Margin
29.36%
38.53%
0.00
-9.17%
PAT Margin
15.98%
27.11%
0.00
-11.13%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 6,430.65 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 14.50% vs -0.85% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 1,027.32 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 47.07% vs -9.57% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,629.55 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 28.42% vs -4.81% in Mar 2025

Annual - Interest
Interest 33.28 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -20.76% vs 60.31% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.34%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."